Dean Trantham
Family Medicine · Easley, SCNPI 1740778513
Payments from drug & device makers
Across 144 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$650
- Novo Nordisk$447
- AbbVie$218
- Lilly USA, LLC$178
- Dexcom, Inc.$160
- Pfizer$123
- plus $984 from 21 others
What the payments were for
- Food & beverage$2,761100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 33 | $650 |
| Novo Nordisk | 27 | $447 |
| AbbVie | 12 | $218 |
| Lilly USA, LLC | 5 | $178 |
| Dexcom, Inc. | 4 | $160 |
| Pfizer | 8 | $123 |
| AstraZeneca | 7 | $115 |
| Novartis | 6 | $110 |
| Nestle Healthcare Nutrition Inc. | 6 | $97 |
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| Bayer | 5 | $74 |
| Abbott | 3 | $73 |
| Paratek Pharmaceuticals, Inc. | 3 | $63 |
| Amgen | 3 | $54 |
| Astellas Pharma US Inc | 2 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Edwards Lifesciences | 1 | $41 |
| Johnson & Johnson | 3 | $41 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Lucid Diagnostics Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$124
- DEXCOM G7 GSS (161)$120
- TRELEGY ELLIPTA$105
How this compares
$2,761 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $93,262 |
| MounjaroTirzepatide | 35 | $41,032 |
| EliquisApixaban | 52 | $33,580 |
| CaplytaLumateperone Tosylate | 11 | $33,506 |
| LinzessLinaclotide | 53 | $30,246 |
| FarxigaDapagliflozin Propanediol | 52 | $29,101 |
| JardianceEmpagliflozin | 30 | $28,469 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $27,854 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $22,745 |
| XareltoRivaroxaban | 26 | $20,220 |
| TrulicityDulaglutide | 21 | $19,648 |
| VraylarCariprazine Hcl | 11 | $15,319 |
| Aimovig AutoinjectorErenumab-Aooe | 17 | $15,162 |
| SymbicortBudesonide/Formoterol Fumarate | 37 | $10,569 |
| JanuviaSitagliptin Phosphate | 14 | $10,545 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $447 | $93,26254 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $115 | $67,523124 claims |
| Lilly USA, LLCMounjaro, Trulicity | $178 | $60,68056 claims |
| AbbVieLinzess, Vraylar | $218 | $45,56564 claims |
| PfizerEliquis | $123 | $33,58052 claims |
| Boehringer IngelheimJardiance | $16 | $28,46930 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $650 | $28,08751 claims |
| Johnson & JohnsonXarelto | $41 | $20,22026 claims |
| MerckJanuvia | $12 | $10,54514 claims |
| Astellas Pharma US IncMyrbetriq | $48 | $5,31511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Easley
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.